O'Connor Daniel J. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
O'Connor Daniel J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Daniel J. O'Connor is listed in DiaMedica Therapeutics Inc.'s SEC filings as of 2026-06-03, indicating an insider role with the company (such as a director or officer). The provided context does not specify his exact title or tenure. DiaMedica Therapeutics is a biotechnology company focused on developing therapies for kidney disease and stroke; further details about O'Connor's responsibilities would be found in the specific Form 3/4/5 or 8-K filings and the company's investor relations materials.
Role
Insider
Notability
40/100
Board memberships
DiaMedica Therapeutics Inc.
Awards & honors
Listed as an insider in DiaMedica Therapeutics Inc.'s SEC filings as of 2026-06-03.
Daniel J. O'Connor is listed in DiaMedica Therapeutics Inc.'s SEC filings as of 2026-06-03, indicating an insider role with the company (such as a director or officer). The provided context does not specify his exact title or tenure. DiaMedica Therapeutics is a biotechnology company focused on developing therapies for kidney disease and stroke; further details about O'Connor's …
How many SEC Form 4 filings has O'Connor Daniel J. submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of O'Connor Daniel J.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
